Skip to main content

Table 4 Liver and kidney function values at screening, baseline, day 28 and day 56

From: Prospective, randomized, double-blinded, placebo-controlled study on safety and tolerability of the krill powder product in overweight subjects with moderately elevated blood pressure

Parameter

Krill powder, mean value (n = 18)

Krill powder, SD

Placebo, mean value (n = 17)

Placebo, SD

P-value (Krill powder vs. Placebo)

S-ALT (U/I)

 SCR

25.4

12.0

30.5

14.1

 

 BAS

25.8

12.0

32.6

20.9

 

 D28

27.5

14.9

30.0

18.3

0.1231

 D56

27.1

9.0

41.0

33.5

0.2297

S-AST (U/I)

 SCR

23.6

4.5

26.4

5.5

 

 BAS

24.9

5.8

36.1

38.3

 

 D28

27.4

12.5

34.3

37.8

0.2356

 D56

24.3

4.8

34.9

23.9

0.1521

S-GT (U/I)

 SCR

26.0

11.1

29.1

13.7

 

 BAS

27.0

14.3

28.5

13.7

 

 D28

26.2

10.8

28.1

12.5

0.4191

 D56

27.7

11.3

30.1

14.2

0.4160

S-Krea (μmol/L)

 SCR

73.9

10.6

75.8

12.4

 

 BAS

73.5

9.5

75.5

13.6

 

 D28

72.2

12.0

74.6

12.3

0.7920

 D56

72.5

10.9

74.7

14.9

0.9478

  1. SCR screening, BAS baseline, S- ALT serum alanine aminotransferase, S-AST serum aspartate transaminase, S-GT serum gamma glutamyl transferase, S-Krea serum creatinine